Scientific rigor
I bring an evidence-based mindset to decisions beyond the laboratory: define the problem, test assumptions, understand risk, and focus on what the data supports.
Biotechnology executive
Scaling life-science organizations through strategy, process, and innovation.
Operations • Technology • Quality • Digital Transformation
I help biotechnology and life-science organizations solve complex cross-functional problems by aligning operations, quality systems, technology, people, and strategic execution.
My career spans CEO and CTO leadership, CDMO operations, cGMP and ISO 9001 quality systems, biologics manufacturing, digital transformation, and practical AI implementation.
Quality & CompliancecGMP, ISO 9001, audit readiness
Operations & ManufacturingCDMO systems, biologics, scale
Digital Transformation & AIAutomation, knowledge, governance
Strategy & GrowthBoard partnership, execution, change
How I work
Solving complex problems. Building better systems. Delivering meaningful results.
Biotechnology companies rarely struggle because of science alone. They struggle when strategy, quality, operations, technology, and customer needs evolve independently instead of together. My work focuses on bringing those disciplines into alignment so organizations can make better decisions, execute more consistently, and grow without adding unnecessary complexity.
Operational discipline
I build practical systems that clarify priorities, improve accountability, reduce friction, and help teams execute consistently.
Technology with purpose
I use automation and AI to remove repetitive work, improve visibility, and strengthen human decision-making—not to add another layer of complexity.
Results
A track record of operational and financial outcomes.
61%
Revenue growth in the first two years as CEO, driven by strategic refocus and operational improvement across a biologics CDMO.
+27 pts
Gross margin expansion in the same period, reflecting the shift from an unprofitable initiative to a disciplined core-business strategy.
<5 months
Time to achieve ISO 9001:2015 certification from zero, with zero findings, under budget and ahead of schedule.
5 of 6
Years profitable as CEO, with net income improving roughly 10x from the pre-CEO baseline at peak, across a period that included COVID-19 disruption.
Science creates opportunity. Operations creates consistency. Technology creates leverage. Leadership connects all three.
Areas of focus
- Executive and board-level leadership
- Biotechnology and life-science strategy
- CDMO operations and biologics manufacturing
- Quality systems and regulated environments
- Digital transformation and AI implementation
- Cross-functional execution and organizational change
- Commercial and customer strategy
- Scientific commercialization